GlassScriptPhysician profile
Nathaniel Andrew Hamm
NPI 1134477342
$4,585.16
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $2,438 · 2022: $1,200.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,853.36 | 2019-2020 | |
| Reel Surgical, INC. | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $652.07 | 2019-2020 | |
| Misonix INC | $228.17 | 2019-2020 | |
| Organogenesis INC. | $185.98 | 2019 | |
| Horizon Therapeutics Plc | $154.09 | 2019 | |
| Medtronic Vascular, INC. | $119.96 | 2019 | |
| Trilliant Surgical LLC. | $58.74 | 2019 | |
| Melinta Therapeutics, LLC | $46.39 | 2019 | |
| Arthrex, INC. | $30.71 | 2020 | |
| Merck Sharp & Dohme LLC | $25.87 | 2019 | |
| Polarityte, INC. | $14.99 | 2019 | |
| Zyla Life Sciences, INC. | $14.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Hamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.